Ariad's data looks very good. I just couldn't understand how every was saying it would be, before they saw it.
the high dose seems to have a pretty high rate of severe side effects so we should probably see if the lower doses show side effects after people have been on if for awhile.
Merck had a tki that showed some good efficacy but had to be discontinued because of side effects.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.